Travere Therapeutics, Inc.
| CIK |
Ticker |
Name |
Accession Number |
Date |
Form |
| 1438533 |
|
Travere Therapeutics, Inc. |
0001438533-25-000016 |
2025-04-01 16:06:58 |
DEF 14A
|
| 1438533 |
|
Travere Therapeutics, Inc. |
0001438533-24-000012 |
2024-03-27 16:31:04 |
DEF 14A
|
| 1438533 |
|
Travere Therapeutics, Inc. |
0001438533-23-000016 |
2023-04-13 17:12:47 |
DEF 14A
|
| 1438533 |
|
Travere Therapeutics, Inc. |
0001438533-22-000014 |
2022-04-04 17:29:26 |
DEF 14A
|
| 1438533 |
|
Travere Therapeutics, Inc. |
0001438533-21-000012 |
2021-04-16 16:40:43 |
DEF 14A
|
| 1438533 |
|
Travere Therapeutics, Inc. |
0001438533-20-000007 |
2020-04-14 17:28:11 |
DEF 14A
|
| 1438533 |
|
Travere Therapeutics, Inc. |
0001193125-19-097950 |
2019-04-04 16:47:35 |
DEF 14A
|
| 1438533 |
|
Travere Therapeutics, Inc. |
0001438533-18-000012 |
2018-04-04 17:48:39 |
DEF 14A
|
| 1438533 |
|
Travere Therapeutics, Inc. |
0001438533-17-000013 |
2017-04-13 17:38:06 |
DEF 14A
|
| 1438533 |
|
Travere Therapeutics, Inc. |
0001193125-16-529450 |
2016-04-04 16:31:32 |
DEF 14A
|
| 1438533 |
|
Travere Therapeutics, Inc. |
0001193125-15-150227 |
2015-04-27 21:21:38 |
DEF 14A
|
| 1438533 |
|
Travere Therapeutics, Inc. |
0001193125-15-018988 |
2015-01-23 17:01:06 |
DEF 14A
|
| 1438533 |
|
Travere Therapeutics, Inc. |
0001193805-14-000785 |
2014-04-14 15:15:04 |
DEF 14A
|
